Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00447733
Status:
COMPLETED
Last Update Posted:
2012-03-26
First Post:
2007-03-14
Brief Title:
Integrated Treatment to Persons With Mental Disorders and Co-occurring Substance Use Disorders
Sponsor:
University of Oslo
Organization:
University of Oslo
Study Overview
Official Title:
Effects of Integrated Treatment to Persons With Mental Disorders and Co-occurring Substance Use Disorders
Status:
COMPLETED
Status Verified Date:
2012-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ROP
Brief Summary:
The purpose of this study is to determine whether Integrated Treatment is effective in the treatment of anxiety andor depression with co-occurring substance use disorders
Detailed Description:
Patients with mental disorders and co-occuring substance use disorders are characterized by high suicide rates high treatment drop-out rates and long-lasting interpersonal work school health and legal problems Because mental disorders and substance use disorders co-exist and interact it may be important to provide a treatment that addresses the substance misuse and mental health problems in an integrated and comprehensive way Additionally the health services for patients with mental health and substance use disorders are usually provided by different services and health professionals that rarely cooperate or have qualifications on both kinds of disorders This also calls for an integration of the services on an organizational level This approach of integrating services and treatment approaches for both diseases in a comprehensive way is called Integrated Treatment Several studies have shown that Integrated Treatment is effective in treating the comorbidity of severe mental illness and substance use disorders The over-all aim of this study is to evaluate the effects of evidence-based Integrated Treatment in anxiety andor depression with co-occurring substance use disorders The effects of the treatment will be assesses on changes in substance use and psychopathology
Comparison patients receiving treatment-as-usual or non-manualized treatment at general mental health outpatients clinics
Comparison patients receiving treatment-as-usual or non-manualized treatment at general mental health outpatients clinics
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NFR175394V50 | OTHER_GRANT | The Norwegian Research CouncilNFR175394V50 | None |